These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 26924668)

  • 1. A primer on concentrated insulins: what an internist should know.
    Barnosky A; Shah L; Meah F; Emanuele N; Emanuele MA; Mazhari A
    Postgrad Med; 2016 May; 128(4):381-90. PubMed ID: 26924668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concentrated insulins in current clinical practice.
    Schloot NC; Hood RC; Corrigan SM; Panek RL; Heise T
    Diabetes Res Clin Pract; 2019 Feb; 148():93-101. PubMed ID: 30583034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin lispro: its role in the treatment of diabetes mellitus.
    Campbell RK; Campbell LK; White JR
    Ann Pharmacother; 1996 Nov; 30(11):1263-71. PubMed ID: 8913409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basal insulin glargine vs prandial insulin lispro in type 2 diabetes.
    Arnolds S; Rave K
    Lancet; 2008 Aug; 372(9636):370-1; author reply 372. PubMed ID: 18675680
    [No Abstract]   [Full Text] [Related]  

  • 5. Insulin during pregnancy, labour and delivery.
    de Valk HW; Visser GH
    Best Pract Res Clin Obstet Gynaecol; 2011 Feb; 25(1):65-76. PubMed ID: 21186142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concentrated insulin glargine (Toujeo) for diabetes.
    Med Lett Drugs Ther; 2015 May; 57(1468):69-70. PubMed ID: 25941955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin therapy for type 2 diabetes: rescue, augmentation, and replacement of beta-cell function.
    Mayfield JA; White RD
    Am Fam Physician; 2004 Aug; 70(3):489-500. PubMed ID: 15317436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concentrated insulins: the new basal insulins.
    Lamos EM; Younk LM; Davis SN
    Ther Clin Risk Manag; 2016; 12():389-400. PubMed ID: 27022271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid changes during basal insulin peglispro, insulin glargine, or NPH treatment in six IMAGINE trials.
    Ginsberg H; Cariou B; Orchard T; Chen L; Luo J; Bastyr EJ; Bue-Valleskey J; Chang AM; Ivanyi T; Jacober SJ; Hoogwerf BJ
    Diabetes Obes Metab; 2016 Nov; 18(11):1089-1092. PubMed ID: 27486125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Higher concentration insulins: an overview of clinical considerations.
    Reid TS; Schafer F; Brusko C
    Postgrad Med; 2017 Jun; 129(5):554-562. PubMed ID: 28475455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin glargine improves glycemic control and quality of life in type 2 diabetic patients on hemodialysis.
    Toyoda M; Kimura M; Yamamoto N; Miyauchi M; Umezono T; Suzuki D
    J Nephrol; 2012; 25(6):989-95. PubMed ID: 22307438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initiating insulin therapy in elderly patients with Type 2 diabetes: efficacy and safety of lispro mix 25 vs. basal insulin combined with oral glucose-lowering agents.
    Wolffenbuttel BH; Klaff LJ; Bhushan R; Fahrbach JL; Jiang H; Martin S
    Diabet Med; 2009 Nov; 26(11):1147-55. PubMed ID: 19929994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initiation and gradual intensification of premixed insulin lispro therapy versus Basal {+/-} mealtime insulin in patients with type 2 diabetes eating light breakfasts.
    Giugliano D; Tracz M; Shah S; Calle-Pascual A; Mistodie C; Duarte R; Sari R; Woo V; Jiletcovici AO; Deinhard J; Wille SA; Kiljanski J
    Diabetes Care; 2014 Feb; 37(2):372-80. PubMed ID: 24170763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin lispro low mixture twice daily versus basal insulin glargine once daily and prandial insulin lispro once daily in patients with type 2 diabetes requiring insulin intensification: a randomized phase IV trial.
    Tinahones FJ; Gross JL; Onaca A; Cleall S; Rodríguez A
    Diabetes Obes Metab; 2014 Oct; 16(10):963-70. PubMed ID: 24725616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin glargine in the treatment of type 1 and type 2 diabetes.
    Barnett AH
    Vasc Health Risk Manag; 2006; 2(1):59-67. PubMed ID: 17319470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of insulin analogues in pregnancy.
    Lambert K; Holt RI
    Diabetes Obes Metab; 2013 Oct; 15(10):888-900. PubMed ID: 23489521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concentrated insulins: History and critical reappraisal.
    Heinemann L; Beals JM; Malone J; Anderson J; Jacobson JG; Sinha V; Corrigan SM
    J Diabetes; 2019 Apr; 11(4):292-300. PubMed ID: 30264527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of insulin lispro during pregnancy in women with pregestational diabetes mellitus.
    García-Domínguez M; Herranz L; Hillman N; Martín-Vaquero P; Jáñez M; Moya-Chimenti E; Pallardo LF
    Med Clin (Barc); 2011 Nov; 137(13):581-6. PubMed ID: 21376350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucagon-like peptide 1 receptor agonist or bolus insulin with optimized basal insulin in type 2 diabetes.
    Diamant M; Nauck MA; Shaginian R; Malone JK; Cleall S; Reaney M; de Vries D; Hoogwerf BJ; MacConell L; Wolffenbuttel BH;
    Diabetes Care; 2014 Oct; 37(10):2763-73. PubMed ID: 25011946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biosimilars and Novel Insulins.
    Ampudia-Blasco FJ
    Am J Ther; 2020; 27(1):e52-e61. PubMed ID: 31764128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.